CLGN Earnings & Financial Statements
CollPlant Biotechnologies Ltd.
$4.13
+$0.22(+5.63%)
55
Overall
60
Value
58
Tech
47
Quality
Market Cap
$7.81M
Volume
39.70K
52W Range
$2.64 - $26.80
Target Price
$110.00
CLGN earnings and financial statements: CollPlant Biotechnologies Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CLGN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.37M | $515.0K | $10.96M | $299.0K | $15.64M |
| Cost of revenue | $835.0K | $1.63M | $1.99M | -$400.0K | $2.00M |
| Operating income | -$11.48M | -$17.25M | -$7.51M | -$17.10M | $65.0K |
| EBITDA | -$10.57M | -$16.21M | -$5.92M | -$15.85M | $1.01M |
| Net income | -$11.49M | -$17.89M | -$7.02M | -$16.93M | $237.0K |
| EPS (diluted) | $-0.94 | $-1.45 | $-0.62 | $-1.53 | $0.02 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $10.79M | $18.71M | $34.13M | $37.77M | $51.22M |
| Total liabilities | $4.70M | $5.25M | $5.79M | $5.49M | $6.10M |
| Shareholders’ equity | $6.08M | $13.46M | $28.34M | $32.28M | $45.12M |
| Cash and equivalents | $5.59M | $11.91M | $26.67M | $29.65M | $13.15M |
| Long-term debt | $2.03M | $2.27M | $3.16M | $2.38M | $3.09M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$9.42M | -$14.09M | -$2.76M | -$13.70M | $2.50M |
| Capital expenditure | - | - | - | -$1.32M | -$1.56M |
| Free cash flow | -$9.45M | -$14.58M | -$3.72M | -$15.01M | $2.50M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLGN | $4.13 | +5.6% | 39.70K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CollPlant Biotechnologies Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW